Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Mama Bear who wrote (3700)	6/29/1998 3:38:00 PM
From: Nick	Read Replies (1) \| Respond to of 5736

Ms. Payne: SPRX has a market for the BiliCheck, while at the same time Mr. Asensio claims that there is no market for such devices. Both the claims cannot be true. Can you explain the discrepancy. When I called Mr. Asensio, he had no comment on that. Nick

To: Mama Bear who wrote (3700)	6/29/1998 3:42:00 PM
From: JanyBlueEyes	Read Replies (1) \| Respond to of 5736

<<Why do you suppose that CCSI has generated little revenue despite the fact that has this approval?>> From the most recent 10K: The Company believes that selectively establishing strategic relationships with leading medical companies who have established themselves in the medical community for the development, introduction, commercialization and distribution of its products is the appropriate method to begin its efforts in penetrating the medical market...... From a news article 6/8/98: "As previously publicly disclosed, the Company continues to be engaged in late stage negotiations with potential manufacturing and distribution partners. The Company anticipates being able to make an announcement on the outcome of those negotiations shortly....."

To: Mama Bear who wrote (3700)	6/29/1998 3:55:00 PM
From: Robin	Read Replies (1) \| Respond to of 5736

And let's not forget, Barbara, I believe several here have stated that approximately two-thirds of the worldwide market is outside of the United States and SPRX is shipping RIGHT NOW to these. SPRX will get the other third once the FDA approval is obtained and while CCSI continues to work on the best deal they can get for their stockholders. Remember, whoever puts these units in the hands of the doctor's first gets that portion of the disposable income. You can't get market share on the disposables easily if the market has already been saturated with a competitor's product! SPRX is already going after the first 66%, while CCSI waits at the gate! Rockin' Robin